Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 7/2005

01-07-2005 | Original Article

A feasibility study of psychosocial group intervention for breast cancer patients with first recurrence

Authors: Masami Chujo, Ichiro Mikami, Shigemitsu Takashima, Toshiaki Saeki, Shozo Ohsumi, Kenjiro Aogi, Hitoshi Okamura

Published in: Supportive Care in Cancer | Issue 7/2005

Login to get access

Abstract

Goals of work

The effects of psychosocial group interventions on improving quality of life (QOL) for patients with recurrent breast cancer are not well known. The objective of this study was to assess the feasibility of a psychosocial group intervention in Japanese women with first recurrence of breast cancer.

Patients and method

The subjects were consecutively selected from among patients who were diagnosed with a first recurrence of breast cancer. We conducted a 6-week psychosocial group intervention. QOL was assessed using the Profile of Mood States (POMS), the Impact of Event Scale—Revised, the Mental Adjustment to Cancer (MAC) scale, and the European Organization for Research and the Treatment of Cancer (EORTC) Quality of Life Questionnaire—Cancer 30/Breast module 23 (QLQ-C30/Br23) at baseline then immediately and 3 and 6 months after completion of the intervention.

Results

Among 58 eligible patients, written consent was obtained from 28 (48%), and the final evaluation was conducted on 19 subjects. The repeated measured analysis of variance (ANOVA) revealed a significant change in tension–anxiety, depression–dejection, anger–hostility and total mood disturbance on the POMS, helplessness/hopelessness on the MAC scale, and body image and future perspective on the QLQ-C30/Br23. Dunnett’s test revealed a significant difference in these scores between baseline and 3 months after the intervention but no difference between baseline and 6 months after the intervention.

Conclusion

These results suggested the possibility of a short-term effectiveness of the intervention; however the results were inconclusive because of selected small samples.
Literature
1.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–3763CrossRefPubMed
2.
Akechi T, Fukue-Saeki M, Kugaya, Okamura H, Nishiwaki Y, Yamawaki S, Uchitomi Y (2000) Psychometric properties of the Japanese version of the Mental Adjustment to Cancer (MAC) Scale. Psychooncology 9:395–401CrossRefPubMed
3.
Asukai N, Kato H, Kawamura N, Kim Y, Yamamoto K, Kishimoto J, Miyake Y, Nishizono-Maher A (2002) Reliability and validity of the Japanese-language version of the Impact of Event Scale-Revised (IES-R-J): four studies of different traumatic events. J Nerv Ment Dis 190:175–182CrossRefPubMed
4.
Butler L, Koopman C, Classen C, Spiegel D (1999) Traumatic stress life events, and emotional support in women with metastatic breast cancer: cancer-related trauma symptoms associated with past and current stressors. Health Psychol 18:555–560CrossRefPubMed
5.
Butler LD, Koopman C, Cordova MJ, Garlan RW, DiMiceli S, Spiegel D (2003) Psychological distress and pain significantly increase before death in metastatic breast cancer patients. Psychosom Med 65:416–426CrossRefPubMed
6.
Cain EN, Kohorn EI, Quinlan DM, Latimer K, Schwartz PE (1986) Psychosocial benefits of cancer support group. Cancer 57:183–189PubMed
7.
Cella DF, Mahon SM, Donovan MI (1990) Cancer recurrence as a traumatic events, Behav Med 16:15–22
8.
Classen C, Diamond S, Soleman A (1993) Brief supportive-expressive group therapy for women with primary breast cancer: A treatment manual, Psychosocial treatment laboratory breast cancer intervention project, Stanford University School of Medicine Department of Psychiatry and Behavioral Sciences, Stanford, CA 94305
9.
Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-Davis J, Fobair P, Carlson RW, Kraemer HC (2001) Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry 58:494–501
10.
Daneshpour M (1998) Muslim families and family therapy. J Marital Family Ther 24:355–368
11.
Edelman S, Bell DR, Kidman AD (1999) A group cognitive behavior therapy program with metastatic breast cancer patients. Psychooncology 8:295–305PubMed
12.
Edmonds CVI, Gina A. Lockwood, Cunningham AJ (1999) Psychological response to long term group therapy: A randomized trial with metastatic breast cancer patients. Psychooncology 8:74–91CrossRefPubMed
13.
EORTC Quality of Life Group: EORTC-EVIEW OF TRANCELATIONS, http://​www.​ eortc.be/home/qol/ExplQLQ-C30.htm
14.
Fawzy FI, Fawzy NW, Elashoff R (1990) A structured Psychiatric intervention for cancer patients. I. Change over time in methods of coping and affective disturbance. Arch Gen Psychiatry 47:720–725PubMed
15.
Fobair P, Koopman C, Dimiceli S, O’hanlan K, Butler LD, Classen C, Drooker N, Davids HR, Loulan J, Wallsten D, SpiegelD (2002) Psychosocial intervention for lesbians with primary breast cancer. Psychooncology 11:427–438
16.
Frost MH, Suman VJ, Rummans TA, Dose AM, Taylor M, Novotny P, Johnson R, Evans RE (2000) Physical, psychological, and social well-being of women with breast cancer: The influence of disease phase. Psychooncology 9:221–231PubMed
17.
Fukui S, Kamiya M, Koike M, Kugaya A, Okamura H, Nakanishi T, Imoto S, Kanagawa K, Uchitomi Y (2000) Applicability of a western-developed psychosocial group intervention for Japanese patients with primary breast cancer. Psychooncology 9:169–177CrossRefPubMed
18.
Fukui S, Kugaya A, Okamura H, Kamiya M, Koike M, Nakanishi T, Imoto S, Kanagawa K, Uchitomi Y (2000) A psychosocial group intervention for Japanese women with primary breast carcinoma: A randomized controlled trial. Cancer 89:1026–1036CrossRefPubMed
19.
Goodwin PJ., Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, Drysdale E, Hundleby M, Chochinov HM, Navarro M, Speca M, Hunter J (2001) The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719–1726CrossRefPubMed
20.
Horovitz M (1979) Impact of Event Scale: A measure of subjective stress. Psychosom Med 41:209–218PubMed
21.
Hosaka T, Sugiyama Y, Tokuda Y, Okuyama T (2000) Persistent effects of a structured psychiatric intervention on breast cancer patients’ emotions. Psychiatry Clin Neurosci 54:559–563CrossRefPubMed
22.
Hosaka T, Tokuda Y, Sugiyama Y (2000) Effects of a structured psychiatric intervention on cancer patients’ emotions, and coping styles. Int J Clin Oncol 5:188–191
23.
Johnson J (1982) The effect of a patient education course on persons with a chronic illness. Cancer Nurs 5:117–123PubMed
24.
Kissane DW, Bloch S, Smith GC, Miach P, Clarke DM, Ikin J, Love A, Ranieri N, Mckenzie D (2003) Cognitive-existential group psychotherapy for women with primary breast cancer: a randomized controlled trial. Psychooncology 12:532–546CrossRefPubMed
25.
Kobayashi K, Takeda, F, Teramukai S, Gotoh I, Sakai H, Yoneda S, Noguchi Y, Ogasawara H, Yoshida K (1998) A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30(EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer 34:810–815CrossRefPubMed
26.
Kogon MM, Biswas A, Pearl D, Carlson RW, Spiegel D (1997) Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma. Cancer 80:225–230PubMed
27.
Koopman C, Hermanson K, Diamond S, Angell K, Spiegel D (1998) Social support, life stress, pain and emotional adjustment to advanced breast cancer. Psychooncology 7:101–111CrossRefPubMed
28.
Mcenvon MD, McCorkle R (1990) Quality of life issues in patients with disseminated breast cancer. Cancer 66:1416–1421PubMed
29.
McLachlan SA, Gerald MD, Goodwin PJ (1999) Factor analysis of the psychosocial items of the EORTC QLQ-C30 in metastatic breast cancer patients participating in a psychosocial intervention study. Qual Life Res 8:311–317CrossRefPubMed
30.
McNair DM, Lorr M, Droppleman LF (1971) Manual for the Profile of Mood States (POMS). Educational and Industrial Testing Service, San Diego
31.
Okamura H, Watanabe T, Narabayashi M, Katsumata N, Ando M, Adachi I, Akechi T, Uchitomi Y (2000) Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors. Breast Cancer Res Treat 61:131–137CrossRefPubMed
32.
Okamura H, Fukui S, Nagasaka Y, Koike M, Uchitomi Y (2003) Psychoeducational intervention for patients with primary breast cancer and patient satisfaction with information: an exploratory analysis. Breast Cancer Res Treat 80:331–338CrossRefPubMed
33.
Pinder KL, Ramirez AJ, Black ME, Richards MA, Gregory WM, Rubens RD (1993) Psychiatric disorder in patients with advanced breast cancer: prevalence and associated factors. Eur J Cancer 29:524–527
34.
Sheard T, Maguire P (1999) The effect of psychological intervention on anxiety and depression in cancer patients: results of two meta-analyses. Br J Cancer 80:1770–1780CrossRefPubMed
35.
Silberfarb PM, Maurer LH, Crouthamel CS (1980) Psychosocial aspects of neoplastic disease: I. Functional status of breast cancer patients during different treatment regimens, Am J Psychiatry 137:450–455
36.
Spiegel D (1999) Psychosocial aspects of breast cancer treatment. Semin Oncol 24:36–47
37.
Spiegel D, Bloom JR (1983) Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 45:333–339PubMed
38.
Spiegel D, Classen C (2000) Group therapy for cancer patients. Basic, New York
39.
Spiegel D, Glafkides MC (1983) Effect of group confrontation with death and dying, Int J Group Psychother 33:432–447
40.
Spiegel D, Boom JR, Yalom I (1981) Group support for patients with metastatic cancer. Arch Gen Psychiatry 38:527–533PubMed
41.
Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini N, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14:2756–2768PubMed
42.
Telch CG, Telch MJ (1986) Group coping skills instruction and supportive group therapy for cancer patients: a comparison of strategies. J Consult Clin Psychol 54:802–808CrossRefPubMed
43.
Uchitomi Y, Sugihara J, Fukue M, Kuramoto Y, Akechi T, Oomori N, Yamawaki S (1994) Psychiatric liaison issues in cancer care in Japan. J Pain Symptom Manage 9:319–324CrossRefPubMed
44.
Watson M (1998) Development of a questionnaire measure of adjustment to cancer, The MAC scale, Psychol Med 18:203
45.
Weiss DS, Marmer CR (1997) The impact of event scale-revised. In: Wilson JP, Keane TM (eds) Assessing psychological trauma and PTSD. Guilford, New York, pp 399–411
46.
Yalom ID, Vinogradov S (1975) The theory and practice of group psychotherapy, Basic, USA
47.
Yokoyama K, Araki S, Kawakami N, Takeshita T (1990) Production of the Japanese edition of profile of mood states (POMS): assessment of reliability and validity (in Japanese). Jpn J Public Health 37:913–918
Metadata
Title
A feasibility study of psychosocial group intervention for breast cancer patients with first recurrence
Authors
Masami Chujo
Ichiro Mikami
Shigemitsu Takashima
Toshiaki Saeki
Shozo Ohsumi
Kenjiro Aogi
Hitoshi Okamura
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 7/2005
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0733-z

Other articles of this Issue 7/2005

Supportive Care in Cancer 7/2005 Go to the issue

Society News

Society News July 2005

Original Article

Impact of chemotherapy-induced neutropenia on quality of life: a prospective pilot investigation

Original Article

Changes in quality of life during palliative chemotherapy for solid cancer

Original Article

Marital and sexual satisfaction in testicular cancer survivors and their spouses

Original Article

Venting direct percutaneous jejunostomy (DPEJ) for drainage of malignant bowel obstruction in patients operated on for gastric cancer

Erratum

Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits